|
1
|
Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial.
|
Ann Intern Med
|
2010
|
2.94
|
|
2
|
Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
|
Clin Pharmacol Ther
|
2006
|
2.49
|
|
3
|
Identifying and characterizing adolescent smoking trajectories.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
2.21
|
|
4
|
Neural substrates of abstinence-induced cigarette cravings in chronic smokers.
|
J Neurosci
|
2007
|
2.11
|
|
5
|
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
|
Neuropsychopharmacology
|
2006
|
1.93
|
|
6
|
Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study.
|
Pharmacol Biochem Behav
|
2008
|
1.90
|
|
7
|
Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial.
|
Ann Intern Med
|
2004
|
1.57
|
|
8
|
Smoking topography predicts abstinence following treatment with nicotine replacement therapy.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.38
|
|
9
|
Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy.
|
J Subst Abuse Treat
|
2005
|
1.28
|
|
10
|
Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.
|
Nicotine Tob Res
|
2004
|
1.24
|
|
11
|
Treating tobacco dependence in women.
|
J Womens Health (Larchmt)
|
2007
|
1.23
|
|
12
|
Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion.
|
Nicotine Tob Res
|
2005
|
1.20
|
|
13
|
Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence.
|
Neuropsychopharmacology
|
2010
|
1.17
|
|
14
|
Pharmacogenetics and nicotine addiction treatment.
|
Pharmacogenomics
|
2005
|
1.13
|
|
15
|
Reduced nicotine reward in obesity: cross-comparison in human and mouse.
|
Psychopharmacology (Berl)
|
2005
|
1.05
|
|
16
|
Do small lapses predict relapse to smoking behavior under bupropion treatment?
|
Nicotine Tob Res
|
2004
|
1.03
|
|
17
|
Effecting behavior change: awareness of family history.
|
Am J Prev Med
|
2003
|
1.00
|
|
18
|
Treating tobacco dependence: state of the science and new directions.
|
J Clin Oncol
|
2005
|
0.98
|
|
19
|
Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm.
|
Psychopharmacology (Berl)
|
2005
|
0.97
|
|
20
|
Changes in food reward following smoking cessation: a pharmacogenetic investigation.
|
Psychopharmacology (Berl)
|
2004
|
0.97
|
|
21
|
Sex heterogeneity in pharmacogenetic smoking cessation clinical trials.
|
Drug Alcohol Depend
|
2009
|
0.89
|
|
22
|
Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment.
|
Pharmacogenomics J
|
2008
|
0.87
|
|
23
|
Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial.
|
Nicotine Tob Res
|
2007
|
0.85
|
|
24
|
A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial.
|
Health Commun
|
2011
|
0.83
|
|
25
|
Mouse model predicts effects of smoking and varenicline on event-related potentials in humans.
|
Nicotine Tob Res
|
2010
|
0.81
|
|
26
|
Effects of reproductive history on symptoms of menopause: a brief report.
|
Menopause
|
2011
|
0.79
|
|
27
|
Translating basic science to improve pharmacotherapy for nicotine dependence.
|
Nicotine Tob Res
|
2007
|
0.76
|
|
28
|
Role of perceived stress in the occurrence of preterm labor and preterm birth among urban women.
|
J Midwifery Womens Health
|
2014
|
0.75
|
|
29
|
Weight status and weight-management behaviors among Philadelphia high school students, 2007-2011.
|
Prev Chronic Dis
|
2013
|
0.75
|
|
30
|
Correlates of blood pressure control behaviors among Korean Americans in the greater Philadelphia area.
|
Psychol Rep
|
2013
|
0.75
|